Grassi Investment Management Abbott Laboratories Transaction History

Grassi Investment Management

  • $1.08 Billion
  • Q1 2025

A detailed history of Grassi Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Grassi Investment Management holds 122,406 shares of ABT stock, worth $16 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares
122,406
Previous 123,054 0.53%
Holding current value
$16 Million
Previous $13.9 Million 16.65%
% of portfolio
1.5%
Previous 1.19%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 10, 2025
SELL
$111.1 - $140.22 $71,992 - $90,862
-648 Reduced 0.53%
122,406 $16.2 Million
Q4 2024

Jan 13, 2025
SELL
$111.93 - $119.39 $170,469 - $181,830
-1,523 Reduced 1.22%
123,054 $13.9 Million
Q3 2024

Oct 22, 2024
SELL
$100.07 - $118.13 $70,449 - $83,163
-704 Reduced 0.56%
124,577 $14.2 Million
Q2 2024

Jul 09, 2024
BUY
$100.73 - $112.44 $1.34 Million - $1.5 Million
13,350 Added 11.93%
125,281 $13 Million
Q1 2024

Apr 10, 2024
BUY
$109.52 - $120.96 $13,690 - $15,120
125 Added 0.11%
111,931 $12.7 Million
Q3 2023

Oct 11, 2023
SELL
$95.53 - $114.62 $4,776 - $5,731
-50 Reduced 0.04%
111,806 $10.8 Million
Q1 2023

Apr 11, 2023
SELL
$96.86 - $114.01 $27,508 - $32,378
-284 Reduced 0.25%
111,856 $11.3 Million
Q4 2022

Jan 10, 2023
SELL
$95.06 - $111.52 $9,506 - $11,152
-100 Reduced 0.09%
112,140 $12.3 Million
Q3 2022

Oct 12, 2022
SELL
$96.76 - $112.03 $24,190 - $28,007
-250 Reduced 0.22%
112,240 $10.9 Million
Q2 2022

Jul 12, 2022
SELL
$102.07 - $123.37 $71,449 - $86,359
-700 Reduced 0.62%
112,490 $12.2 Million
Q1 2022

Apr 12, 2022
SELL
$114.02 - $139.04 $11,402 - $13,904
-100 Reduced 0.09%
113,190 $13.4 Million
Q4 2021

Jan 13, 2022
BUY
$115.53 - $141.46 $23,106 - $28,292
200 Added 0.18%
113,290 $15.9 Million
Q3 2021

Oct 12, 2021
BUY
$116.66 - $129.06 $61,246 - $67,756
525 Added 0.47%
113,090 $13.4 Million
Q2 2021

Jul 09, 2021
SELL
$105.79 - $124.53 $4,337 - $5,105
-41 Reduced 0.04%
112,565 $13.1 Million
Q1 2021

Apr 12, 2021
SELL
$108.84 - $128.23 $43,536 - $51,291
-400 Reduced 0.35%
112,606 $13.5 Million
Q4 2020

Jan 19, 2021
SELL
$105.0 - $114.42 $296,625 - $323,236
-2,825 Reduced 2.44%
113,006 $12.4 Million
Q3 2020

Oct 13, 2020
SELL
$91.64 - $111.29 $217,645 - $264,313
-2,375 Reduced 2.01%
115,831 $12.6 Million
Q2 2020

Jul 15, 2020
SELL
$76.57 - $98.0 $99,540 - $127,400
-1,300 Reduced 1.09%
118,206 $10.8 Million
Q1 2020

Apr 08, 2020
SELL
$62.82 - $91.86 $116,217 - $169,941
-1,850 Reduced 1.52%
119,506 $9.43 Million
Q4 2019

Jan 10, 2020
SELL
$78.51 - $87.4 $71,051 - $79,097
-905 Reduced 0.74%
121,356 $10.5 Million
Q3 2019

Oct 04, 2019
SELL
$81.84 - $88.74 $100,254 - $108,706
-1,225 Reduced 0.99%
122,261 $10.2 Million
Q2 2019

Jul 10, 2019
BUY
$72.88 - $85.0 $7,360 - $8,585
101 Added 0.08%
123,486 $10.4 Million
Q1 2019

Apr 10, 2019
BUY
$66.22 - $80.06 $19,932 - $24,098
301 Added 0.24%
123,385 $9.86 Million
Q4 2018

Jan 10, 2019
SELL
$65.56 - $74.27 $50,809 - $57,559
-775 Reduced 0.63%
123,084 $8.9 Million
Q3 2018

Oct 12, 2018
BUY
$60.81 - $73.36 $47,188 - $56,927
776 Added 0.63%
123,859 $9.09 Million
Q2 2018

Jul 10, 2018
BUY
$57.57 - $63.54 $19,631 - $21,667
341 Added 0.28%
123,083 $7.51 Million
Q4 2017

Jan 10, 2018
BUY
$53.68 - $57.47 $338,237 - $362,118
6,301 Added 5.41%
122,742 $7.01 Million
Q3 2017

Oct 10, 2017
BUY
$48.06 - $53.64 $5.6 Million - $6.25 Million
116,441
116,441 $6.21 Million

Others Institutions Holding ABT

# of Institutions
3,464
Shares Held
1.34B
Call Options Held
10.5M
Put Options Held
8.72M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Grassi Investment Management Portfolio

Follow Grassi Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grassi Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Grassi Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email